ÖÐÎÄÃû³Æ£ºBCCIP¿¹Ô£¨ÖØ×éµ°°×£©
Ó¢ÎÄÃû³Æ£º BCCIP Antigen (Recombinant Protein)
±ð Ãû£º TOK1; TOK-1
´¢ ´æ£º Àä¶³£¨-20¡æ£©
Ïà¹ØÀà±ð£º ¿¹Ô
¸Å Êö£º
|
Fusion protein corresponding to a region derived from 59-167 amino acids of human BCCIP |
|
Full name: |
BRCA2 and CDKN1A interacting protein |
|
Synonyms: |
TOK1; TOK-1 |
|
Swissprot: |
Q9P287 |
|
Gene Accession: |
BC009771 |
|
Purity: |
>85%, as determined by Coomassie blue stained SDS-PAGE |
|
Expression system: |
Escherichia coli |
|
Tags: |
His tag C-Terminus, GST tag N-Terminus |
|
Background: |
This gene product was isolated on the basis of its interaction with BRCA2 and p21 proteins. It is an evolutionarily conserved nuclear protein with multiple interacting domains. The N-terminal half shares moderate homology with regions of calmodulin and M-calpain, suggesting that it may also bind calcium. Functional studies indicate that this protein may be an important cofactor for BRCA2 in tumor suppression, and a modulator of CDK2 kinase activity via p21. This protein has also been implicated in the regulation of BRCA2 and RAD51 nuclear focus formation, double-strand break-induced homologous recombination, and cell cycle progression. Multiple transcript variants encoding different isoforms have been described for this gene. |
¹ºÎï³µ
°ïÖú
021-54845833/15800441009
